Aliskiren

Circulation - United States
doi 10.1161/circulationaha.108.787630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Synthesis of Aliskiren

Synfacts
2010English

Direct Renin Inhibition: Focus on Aliskiren

Journal of Managed Care Pharmacy
2007English

Aliskiren Improves Nitric Oxide Bioavailability and Limits Atherosclerosis

Hypertension
Internal Medicine
2008English

Neurohumoral Effects of Aliskiren in Patients With Symptomatic Heart Failure Receiving a Mineralocorticoid Receptor Antagonist: The Aliskiren Observation of Heart Failure Treatment Study

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2011English

Antihypertensive Efficacy of Aliskiren: Is Hydrochlorothiazide an Appropriate Benchmark?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Effects of Aliskiren on Hemodynamic Parametersin Daunorubicin -Induced Acute Cardiomyopathy in Rats

Journal of Drug Delivery and Therapeutics
2019English

Renin-Angiotensin-Aldosterone System in the Elderly: Rational Use of Aliskiren in Managing Hypertension

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2009English

Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression: Comparison With Irbesartan, Atenolol, and Amlodipine

Hypertension
Internal Medicine
2008English

Efficacy of Aliskiren/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Meta-Analytical Approach

Open Cardiovascular Medicine Journal
Cardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy